A detailed history of Adalta Capital Management LLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, Adalta Capital Management LLC holds 90,260 shares of MRK stock, worth $11.4 Million. This represents 7.25% of its overall portfolio holdings.

Number of Shares
90,260
Previous 89,080 1.32%
Holding current value
$11.4 Million
Previous $9.71 Million 22.63%
% of portfolio
7.25%
Previous 6.47%

Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

BUY
$113.24 - $131.95 $133,623 - $155,701
1,180 Added 1.32%
90,260 $11.9 Million
Q4 2023

Feb 14, 2024

SELL
$100.18 - $109.02 $12,021 - $13,082
-120 Reduced 0.13%
89,080 $9.71 Million
Q3 2023

Nov 14, 2023

BUY
$102.95 - $114.33 $16,060 - $17,835
156 Added 0.18%
89,200 $9.25 Million
Q1 2023

May 16, 2023

BUY
$102.94 - $114.86 $3,499 - $3,905
34 Added 0.04%
89,044 $9.47 Million
Q4 2022

Feb 17, 2023

SELL
$87.44 - $112.11 $17,488 - $22,422
-200 Reduced 0.22%
89,010 $9.94 Million
Q2 2022

Aug 16, 2022

SELL
$83.49 - $94.64 $2,087 - $2,366
-25 Reduced 0.03%
89,210 $8.19 Million
Q4 2021

Feb 15, 2022

BUY
$72.28 - $90.54 $948,675 - $1.19 Million
13,125 Added 17.24%
89,235 $6.89 Million
Q3 2021

Nov 16, 2021

SELL
$71.68 - $78.83 $2,867 - $3,153
-40 Reduced 0.05%
76,110 $5.77 Million
Q2 2021

Aug 17, 2021

BUY
$70.31 - $77.77 $3,515 - $3,888
50 Added 0.07%
76,150 $5.97 Million
Q1 2021

May 18, 2021

SELL
$68.86 - $81.11 $63,695 - $75,026
-925 Reduced 1.2%
76,100 $5.92 Million
Q4 2020

Feb 17, 2021

BUY
$71.77 - $79.65 $26,913 - $29,868
375 Added 0.49%
77,025 $6.35 Million
Q3 2020

Nov 17, 2020

BUY
$73.18 - $82.95 $5,488 - $6,221
75 Added 0.1%
76,650 $6.41 Million
Q2 2020

Aug 14, 2020

SELL
$70.42 - $80.13 $44,364 - $50,481
-630 Reduced 0.82%
76,575 $5.97 Million
Q1 2020

May 18, 2020

SELL
$63.36 - $87.82 $162,518 - $225,258
-2,565 Reduced 3.22%
77,205 $5.99 Million
Q4 2019

Feb 14, 2020

SELL
$77.58 - $87.54 $38,790 - $43,770
-500 Reduced 0.62%
79,770 $7.3 Million
Q3 2019

Nov 15, 2019

BUY
$76.08 - $82.93 $9,510 - $10,366
125 Added 0.16%
80,270 $6.8 Million
Q2 2019

Aug 14, 2019

BUY
$69.84 - $81.59 $282,852 - $330,439
4,050 Added 5.32%
80,145 $6.76 Million
Q1 2019

May 16, 2019

BUY
$69.58 - $79.36 $62,622 - $71,424
900 Added 1.2%
76,095 $6.37 Million
Q4 2018

Feb 15, 2019

SELL
$65.24 - $75.71 $65,239 - $75,710
-1,000 Reduced 1.31%
75,195 $5.79 Million
Q2 2018

Aug 15, 2018

SELL
$50.83 - $59.72 $13,978 - $16,423
-275 Reduced 0.36%
76,195 $4.66 Million
Q1 2018

May 16, 2018

BUY
$50.96 - $59.23 $5,350 - $6,219
105 Added 0.14%
76,470 $4.2 Million
Q4 2017

Feb 14, 2018

SELL
$51.62 - $61.64 $92,916 - $110,952
-1,800 Reduced 2.3%
76,365 $4.33 Million
Q3 2017

Nov 24, 2017

BUY
$58.67 - $63.13 $4.59 Million - $4.93 Million
78,165
78,165 $5.04 Million

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $319B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Adalta Capital Management LLC Portfolio

Follow Adalta Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Adalta Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Adalta Capital Management LLC with notifications on news.